Clearly IMU entering the ASX200 3 years ago for trader and shorter to take control of the stock certainly doesn't help the pps now but it does give the opportunity for LT to accumulate cheap shares for longer period while IMU just continue with the science, there will be a clinical trial update catalyst when the US big boys decide to buy and take control.
Add to My Watchlist
What is My Watchlist?